54
Views
112
CrossRef citations to date
0
Altmetric
Review Article

Genetic metabolic polymorphisms and the risk of cancer: a review of the literature

, , &
Pages 149-173 | Received 31 Jan 1996, Accepted 26 Mar 1996, Published online: 27 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Vanessa Da Silva Silveira, Renata Canalle, Carlos Alberto Scrideli, Rosane Gomes de Paula Queiroz & Luiz Gonzaga Tone. (2009) Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a Brazilian population. Biomarkers 14:2, pages 111-117.
Read now
R. C. Sobti, Pushpinder Kaur, Satinder Kaur, A. K. Janmeja, S. K. Jindal, J. Kishan & Sara Raimondi. (2008) Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer. Biomarkers 13:3, pages 282-295.
Read now
F. Peter Guengerich. (2004) Cytochrome P450: What Have We Learned and What Are the Future Issues?. Drug Metabolism Reviews 36:2, pages 159-197.
Read now
F. Peter Guengerich. (2002) Update Information on Human P450s. Drug Metabolism Reviews 34:1-2, pages 7-15.
Read now
Gabriele Sabbioni & Christopher R. Jones. (2002) Biomonitoring of arylamines and nitroarenes. Biomarkers 7:5, pages 347-421.
Read now
Daniel Sinnett, Maja Krajinovic & Damian Labuda. (2000) Genetic Susceptibility to Childhood Acute Lymphoblastic Leukemia. Leukemia & Lymphoma 38:5-6, pages 447-462.
Read now
Lars W. Wormhoudt, Jan N. M. Commandeur & Nico P. E. Vermeulen. (1999) Genetic Polymorphisms of Human N-Acetyltransferase, Cytochrome P450, Glutathione-S-Transferase, and Epoxide Hydrolase Enzymes: Relevance to Xenobiotic Metabolism and Toxicity. Critical Reviews in Toxicology 29:1, pages 59-124.
Read now
Christine Bouchardy, Harriet Wikman, Simone Benhamou, Ari Hirvonen, Pierre Dayer & Kirsti Husgafvel-Pursiainen. (1997) CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population. Biomarkers 2:2, pages 131-134.
Read now
Neil Caporaso. (1996) Genetic susceptibility and the common cancers. Biomarkers 1:3, pages 174-177.
Read now

Articles from other publishers (103)

Mohammad Waseem, Hadiya Husain & Imran Ahmad. 2021. Obesity and Cancer. Obesity and Cancer 129 142 .
F.P. Guengerich. 2018. Comprehensive Toxicology. Comprehensive Toxicology 54 86 .
Zakiullah Zakiullah, Ahmadullah Ahmadullah, Muhammad Khisroon, Muhammad Saeed, Ajmal Khan, Fazli Khuda, Sajid Ali, Nabila Javed, Muhammad Ovais, Nosheen Masood, Nasir Khan Khalil & Mohammad Ismail. (2015) Genetic Susceptibility to Oral Cancer due to Combined Effects of GSTT1, GSTM1 and CYP1A1 Gene Variants in Tobacco Addicted Patients of Pashtun Ethnicity of Khyber Pakhtunkhwa Province of Pakistan. Asian Pacific Journal of Cancer Prevention 16:3, pages 1145-1150.
Crossref
F. Peter Guengerich. 2015. Cytochrome P450. Cytochrome P450 523 785 .
Neil Caporaso. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online.
Zakiullah Zakiullah, Muhammad Saeed, Sajid Ali, Nabila Javed, Muhammad Khisroon, Basir Muhammad, Fazli Khuda, Saeed Ahmad & Mohammad Ismail. (2014) Genetic Susceptibility to Esophageal Cancer due to CYP1A1 Gene Variant rs4646903 in Tobacco Addicted Patients of Pashtun Ethnicity: a Case Control Study in Khyber Pakhtunkhwa Province of Pakistan. Asian Pacific Journal of Cancer Prevention 15:16, pages 6715-6720.
Crossref
Mohammad Abbas, Kirti Srivastava, Mohd Imran & Monisha Banerjee. (2014) Association of CYP1A1 gene variants rs4646903 (T>C) and rs1048943 (A>G) with cervical cancer in a North Indian population. European Journal of Obstetrics & Gynecology and Reproductive Biology 176, pages 68-74.
Crossref
F. Peter Guengerich. 2014. Fifty Years of Cytochrome P450 Research. Fifty Years of Cytochrome P450 Research 17 41 .
I-Shen Lin, Pao-Lou Fan, Hong-I Chen, Ching-Hui Loh, Tung-Sheng Shih & Saou-Hsing Liou. (2013) Rapid and intermediate N-acetylators are less susceptible to oxidative damage among 4,4′-methylenebis(2-chloroaniline) (MBOCA)-exposed workers. International Journal of Hygiene and Environmental Health 216:4, pages 515-520.
Crossref
Xujun Ye, Yi Jiang, Hua Wang, Ling Chen, Sheng Yuan & Bing Xia. (2011) Genetic polymorphisms of glutathione S-transferases are associated with ulcerative colitis in central China. Cell Biochemistry and Biophysics 60:3, pages 323-328.
Crossref
Chunming Gong, Xueying Hu, Yong Gao, Yunfei Cao, Feng Gao & Zengnan Mo. (2010) A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review. Medical Oncology 28:1, pages 365-376.
Crossref
Scott M. Langevin, John P.A. Ioannidis, Paolo Vineis & Emanuela Taioli. (2010) Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines. Pharmacogenetics and Genomics 20:10, pages 586-597.
Crossref
K. Sabitha, M. Vishnuvardhan Reddy & Kaiser Jamil. (2010) Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer. Cancer Epidemiology 34:5, pages 587-592.
Crossref
F.P. Guengerich. 2010. Comprehensive Toxicology. Comprehensive Toxicology 41 76 .
Ranbir C. SobtiPushpinder KaurSatinder KaurAshok K. JanmejaSurinder K. JindalJai KishanSara Raimondi. (2009) Impact of Interaction of Polymorphic Forms of p53 Codon 72 and N- Acetylation Gene ( NAT2 ) on the Risk of Lung Cancer in the North Indian Population . DNA and Cell Biology 28:9, pages 443-449.
Crossref
Chikako Kiyohara & Kouichi Yoshimasu. (2009) Molecular epidemiology of major depressive disorder. Environmental Health and Preventive Medicine 14:2, pages 71-87.
Crossref
K.G. Manton, Igor Akushevich & Julia KravchenkoK.G. Manton, Igor Akushevich & Julia Kravchenko. 2009. Cancer Mortality and Morbidity Patterns in the U.S. Population. Cancer Mortality and Morbidity Patterns in the U.S. Population 89 149 .
Manjula Kiran, Yogesh Kumar ChawlaJyotdeep Kaur. (2008) Glutathione-S-Transferase and Microsomal Epoxide Hydrolase Polymorphism and Viral-Related Hepatocellular Carcinoma Risk in India. DNA and Cell Biology 27:12, pages 687-694.
Crossref
C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke & J. P. T. Higgins. (2008) Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis. American Journal of Epidemiology 167:7, pages 759-774.
Crossref
F. Peter Guengerich. (2007) Cytochrome P450 and Chemical Toxicology. Chemical Research in Toxicology 21:1, pages 70-83.
Crossref
Necati Muslu, Zeynep Nil Dogruer, Gulcin Eskandari, Aytug Atici, Seval Kul & Ugur Atik. (2007) Are glutathione S-transferase gene polymorphisms linked to neonatal jaundice?. European Journal of Pediatrics 167:1, pages 57-61.
Crossref
Bour‐Jr Wang, Judith‐Sc Shiao, Chiou‐Jong Chen, Yeu‐Chin Lee & Yue‐Liang Guo. (2007) Tumour necrotizing factor‐α promoter and GST‐T1 genotype predict skin allergy to chromate in cement workers in Taiwan. Contact Dermatitis 57:5, pages 309-315.
Crossref
Daniel Sinnett, Nina N’Diaye, Pascal St-Onge & Jasmine Healy. (2007) La leucémie de l’enfant. médecine/sciences 23:11, pages 968-974.
Crossref
Renata dos Santos Coura, Christiane de Fátima Silva Marques, Rosalina J. Koifman, Sergio Koifman, Pedro Hernan Cabello & Ana Hatagima. (2007) CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population. Genetics and Molecular Biology 30:1, pages 1-5.
Crossref
Adrian Cassidy & John K. Field. 2007. Outcome Prediction in Cancer. Outcome Prediction in Cancer 67 100 .
Thomas Joseph, Priya Chacko, Remani Wesley, P.G. Jayaprakash, Francis V. James & M. Radhakrishna Pillai. (2006) Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: Associations with tumor progression, age and human papillomavirus infection. Gynecologic Oncology 101:3, pages 411-417.
Crossref
Pei Chien Tsai, Wenya Huang, Yeu-Chin Lee, Shih Huang Chan & Yueliang Leon Guo. (2006) Genetic polymorphisms in CYP1A1 and GSTM1 predispose humans to PCBs/PCDFs-induced skin lesions. Chemosphere 63:8, pages 1410-1418.
Crossref
William W. AU. (2006) Heritable Susceptibility Factors for the Development of Cancer. Journal of Radiation Research 47:SupplementB, pages B13-B17.
Crossref
José M. Ladero, Carmen Martínez, Elena García-Martín, Paloma Ropero, Olga Briceño, Ana Villegas, Manuel Díaz-Rubio & José A.G. Agúndez. (2006) Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: A study in the Spanish population. European Journal of Cancer 42:1, pages 73-77.
Crossref
S. Egal, A. Hounsa, Y.Y. Gong, P.C. Turner, C.P. Wild, A.J. Hall, K. Hell & K.F. Cardwell. (2005) Dietary exposure to aflatoxin from maize and groundnut in young children from Benin and Togo, West Africa. International Journal of Food Microbiology 104:2, pages 215-224.
Crossref
Montserrat García-Closas, Núria Malats, Debra Silverman, Mustafa Dosemeci, Manolis Kogevinas, David W Hein, Adonina Tardón, Consol Serra, Alfredo Carrato, Reina García-Closas, Josep Lloreta, Gemma Castaño-Vinyals, Meredith Yeager, Robert Welch, Stephen Chanock, Nilanjan Chatterjee, Sholom Wacholder, Claudine Samanic, Montserrat Torà, Francisco Fernández, Francisco X Real & Nathaniel Rothman. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. The Lancet 366:9486, pages 649-659.
Crossref
John Timbrell. 2005. Metabonomics in Toxicity Assessment. Metabonomics in Toxicity Assessment 27 74 .
Charlotta Ryk, Petra Berggren, Rajiv Kumar, Kari Hemminki, Per Larsson, Gunnar Steineck, Bo Lambert & Sai-Mei Hou. (2005) Influence ofGSTM1, GSTT1, GSTP1 andNAT2 genotypes on thep53 mutational spectrum in bladder tumours. International Journal of Cancer 113:5, pages 761-768.
Crossref
Neil Caporaso. 2005. Encyclopedia of Biostatistics. Encyclopedia of Biostatistics.
Hatice Pinarbasi, Yavuz Silig & Mustafa Gurelik. (2005) Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genetics and Cytogenetics 156:2, pages 144-149.
Crossref
F. Peter Guengerich. 2005. Cytochrome P450. Cytochrome P450 377 530 .
David M. DeMarini. (2004) Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutation Research/Reviews in Mutation Research 567:2-3, pages 447-474.
Crossref
Jana Šarmanová, Simona Šůsová, Ivan Gut, Marcela Mrhalová, Roman Kodet, Jan Adámek, Zdeněk Roth & Pavel Souček. (2004) Breast cancer: role of polymorphisms in biotransformation enzymes. European Journal of Human Genetics 12:10, pages 848-854.
Crossref
Thomas Joseph, P. Kusumakumary, Priya Chacko, Annie Abraham & M. Radhakrishna Pillai. (2004) Genetic polymorphism ofCYP1A1,CYP2D6,GSTM1 andGSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatric Blood & Cancer 43:5, pages 560-567.
Crossref
Xifeng Wu, Hua Zhao, Rebecca Suk & David C Christiani. (2004) Genetic susceptibility to tobacco-related cancer. Oncogene 23:38, pages 6500-6523.
Crossref
Alberto Izzotti & Sergio C Saccà. (2004) Glutathione S-transferase M1 and its implications in glaucoma pathogenesis: a controversial matterDOI of the original article: 10.1016/S0014-4835(03)00109-X. Experimental Eye Research 79:1, pages 141-142.
Crossref
Christelle Cauffiez, Jean-Marc Lo-Guidice, Sylvie Quaranta, Delphine Allorge, Dany Chevalier, Sylvie Cenée, Rima Hamdan, Michel Lhermitte, Jean-Jacques Lafitte, Christian Libersa, Jean-Frédéric Colombel, Isabelle Stücker & Franck Broly. (2004) Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochemical and Biophysical Research Communications 317:2, pages 662-669.
Crossref
Paola Turella, Jens Z. Pedersen, Anna Maria Caccuri, Francesca De Maria, Piergiorgio Mastroberardino, Mario Lo Bello, Giorgio Federici & Giorgio Ricci. (2003) Glutathione Transferase Superfamily Behaves Like Storage Proteins for Dinitrosyl-Diglutathionyl-Iron Complex in Heterogeneous Systems. Journal of Biological Chemistry 278:43, pages 42294-42299.
Crossref
Hatice Pinarbasi, Yavuz Silig, Oge Cetinkaya, Zehra Seyfikli & Ergun Pinarbasi. (2003) Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genetics and Cytogenetics 146:2, pages 125-129.
Crossref
George Davey Smith & Shah Ebrahim. (2003) ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*. International Journal of Epidemiology 32:1, pages 1-22.
Crossref
Roger W.L. Godschalk, Frederik-Jan Van Schooten & Helmut Bartsch. (2003) A Critical Evaluation of DNA Adducts as Biological Markers for Human Exposure to Polycyclic Aromatic Compounds. BMB Reports 36:1, pages 1-11.
Crossref
Sheila A Bingham. (2006) Biomarkers in nutritional epidemiology. Public Health Nutrition 5:6a, pages 821-827.
Crossref
Sarah J. Lewis, Nicola M. Cherry, Robert McL. Niven, Phillip V. Barber & Andrew C. Povey. (2002) GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Letters 180:2, pages 165-171.
Crossref
Steven S Coughlin & Ingrid J Hall. (2002) A Review of Genetic Polymorphisms and Prostate Cancer Risk. Annals of Epidemiology 12:3, pages 182-196.
Crossref
Bensu Karahalil, Semra Şardaş, Neslihan Aygün Kocabaş, Ela Alhayiroğlu, Ali Esat Karakaya & Eren Civelek. (2002) Chromosomal aberrations under basal conditions and after treatment with X-ray in human lymphocytes as related to the GSTM1 genotype. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 515:1-2, pages 135-140.
Crossref
Seung-Joon Lee, Soo-Hun Cho, Sue Kyung Park, Soo-Woong Kim, Moon Soo Park, Han-Yong Choi, Ji-Yeob Choi, Sang-Yoon Lee, Hyoung-June Im, Jae-Yong Kim, Ki Jung Yoon, Hwang Choi, Sang-Goo Shin, Tae-Won Park, Nathaniel Rothman, Ari Hirvonen & Daehee Kang. (2002) Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Letters 177:2, pages 173-179.
Crossref
TERHI KULJUKKA-RABB, LARS NYLUND, RAIJA VAARANRINTA, KIRSTI SAVELA, PERTTI MUTANEN, TOOMAS VEIDEBAUM, MARJA SORSA, AGNETA RANNUG & KIMMO PELTONEN. (2002) The effect of relevant genotypes on PAH exposure-related biomarkers. Journal of Exposure Science & Environmental Epidemiology 12:1, pages 81-91.
Crossref
P van den Brandt, L Voorrips, I Hertz-Picciotto, D Shuker, H Boeing, G Speijers, C Guittard, J Kleiner, M Knowles, A Wolk & A Goldbohm. (2002) The contribution of epidemiology. Food and Chemical Toxicology 40:2-3, pages 387-424.
Crossref
Craig K. Svensson & Edith Sim. 2002. Wiley Encyclopedia of Molecular Medicine. Wiley Encyclopedia of Molecular Medicine.
Christof Lamberti, Matthias Jungck, Michael Laarmann, Michael Knapp, Reiner Caspari, Waltraut Friedl, Tilman Sauerbruch, Peter Propping & Roland Kruse. (2002) Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis. Pharmacogenetics 12:1, pages 49-54.
Crossref
Regina M. Santella. 2002. Cancer Precursors. Cancer Precursors 7 19 .
L Quiñones, D Lucas, J Godoy, D Cáceres, F Berthou, N Varela, K Lee, C Acevedo, L Martı́nez, A.M Aguilera & L Gil. (2001) CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Letters 174:1, pages 35-44.
Crossref
Jordi To-Figueras, Manuel Gené, Jesús Gómez-Catalán, Esther Piqué, Natividad Borrego & Jacint Corbella. (2001) Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. Cancer Letters 173:2, pages 155-162.
Crossref
Pavel Vodicka, Pavel Soucek, Ad D Tates, Maria Dusinska, Jana Sarmanova, Maria Zamecnikova, Ludmila Vodickova, Mikko Koskinen, Frans A de Zwart, A.T Natarajan & Kari Hemminki. (2001) Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 482:1-2, pages 89-103.
Crossref
Stefano Bonassi, Monica Neri & Riccardo Puntoni. (2001) Validation of biomarkers as early predictors of disease. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 480-481, pages 349-358.
Crossref
Wai Nang ChoyWerner Lutz. 2001. Genetic Toxicology and Cancer Risk Assessment. Genetic Toxicology and Cancer Risk Assessment 249 270 .
F. Branca, A. B. Hanley, B Pool-Zobel & H. Verhagen. (2007) Biomarkers in disease and health. British Journal of Nutrition 86:S1, pages S55-S92.
Crossref
Roger W. L. Godschalk, Jan W. Dallinga, Harriet Wikman, Angela Risch, Jos C. S. Kleinjans, Helmut Bartsch & Frederik-Jan Van Schooten. (2001) Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1, GSTT1, NAT1 and NAT2. Pharmacogenetics 11:5, pages 389-398.
Crossref
ALBERTO IZZOTTI, CRISTINA CARTIGLIA, JOELLEN LEWTAS & SILVIO DE FLORA. (2001) Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype . The FASEB Journal 15:3, pages 752-757.
Crossref
Susan A. J. Vaziri, Nicola C. Hughes, Heather Sampson, Gerarda Darlington, Michael A. S. Jewett & Denis M. Grant. (2001) Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects. Pharmacogenetics 11:1, pages 7-20.
Crossref
Emanuela Taioli, Daniela Mari, Claudio Franceschi, Massimiliano Bonafè, Daniela Monti, Stefano Bertolini, Daniela Marinelli & Seymour Garte. (2001) Polymorphisms of Drug-Metabolizing Enzymes in Healthy Nonagenarians and Centenarians: Difference at GSTT1 Locus. Biochemical and Biophysical Research Communications 280:5, pages 1389-1392.
Crossref
M. Krajinovic, D. Labuda & D. Sinnett. (2001) Childhood Acute Lymphoblastic Leukemia: Genetic Determinants of Susceptibility and Disease Outcome. Reviews on Environmental Health 16:4.
Crossref
William W. Au, Hye Young Oh, James Grady, Salama A. Salama & Moon Young Heo. (2001) Usefulness of genetic susceptibility and biomarkers for evaluation of environmental health risk. Environmental and Molecular Mutagenesis 37:3, pages 215-225.
Crossref
Suparp Kietthubthew, Hutcha Sriplung & William W. Au. (2001) Genetic and environmental interactions on oral cancer in Southern Thailand. Environmental and Molecular Mutagenesis 37:2, pages 111-116.
Crossref
Jana Sarmanova, Lucie Tynkova, Simona Susova, Ivan Gut & Pavel Soucek. (2000) Pharmacogenetics 10:9, pages 781-788.
Crossref
Graeme I. Murray. (2000) The role of cytochrome P450 in tumour development and progression and its potential in therapy. The Journal of Pathology 192:4, pages 419-426.
Crossref
Ewa Grzybowska, Dorota Butkiewicz, Grażyna Motykiewicz & Mieczyslaw Chorżży. (2000) The effect of the genetic polymorphisms of CYP1A1,CYP2D6, GSTM1 and GSTP1 on aromatic DNA adduct levels in the population of healthy women. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 469:2, pages 271-277.
Crossref
Evgeniya V. Belogubova, Alexandr V. Togo, Tatiana V. Kondratieva, Vladimir G. Lemehov, Kaido P. Hanson & Evgeny N. Imyanitov. (2000) GSTM1 genotypes in elderly tumour-free smokers and non-smokers. Lung Cancer 29:3, pages 189-195.
Crossref
Andrew C. Povey. (2016) DNA Adducts: Endogenous and Induced. Toxicologic Pathology 28:3, pages 405-414.
Crossref
Sirkku T. Saarikoski, Maria Reinikainen, Sisko Anttila, Antti Karjalainen, Harri Vainio, Kirsti Husgafvel-Pursiainen & Ari Hirvonen. (2000) Role of NAT2 deficiency in susceptibility to lung cancer among asbestos-exposed individuals. Pharmacogenetics 10:2, pages 183-185.
Crossref
Pamela M. Marcus, Paolo Vineis & Nathaniel Rothman. (2000) NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case???control studies conducted in the general population. Pharmacogenetics 10:2, pages 115-122.
Crossref
F. Peter Guengerich. (2000) Metabolism of chemical carcinogens. Carcinogenesis 21:3, pages 345-351.
Crossref
Sirkku Saarikoski, Fumihiro Sata, Kirsti Husgafvel-Pursiainen, Matti Rautalahti, Jari Haukka, Olli Impivaara, Jorma Jarvisalo, Harri Vainio & Ari Hirvonen. (2000) Pharmacogenetics 10:1, pages 5-10.
Crossref
J.T. Lear, A.G. Smith, R.C. Strange & A.A. Fryer. (2000) Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. British Journal of Dermatology 142:1, pages 8-15.
Crossref
L Lucero, S Pastor, S Suárez, R Durbán, C Gómez, T Parrón, A Creus & R Marcos. (2000) Cytogenetic biomonitoring of Spanish greenhouse workers exposed to pesticides: micronuclei analysis in peripheral blood lymphocytes and buccal epithelial cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 464:2, pages 255-262.
Crossref
Herman Autrup. (2000) Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 464:1, pages 65-76.
Crossref
F. Peter Guengerich. (2000) Pharmacogenomics of cytochrome P450 and other enzymes involved in biotransformation of xenobiotics. Drug Development Research 49:1, pages 4-16.
Crossref
K Szyfter, Z Szmeja, W Szyfter, K Hemminki, J Banaszewski, R Jaskuła-Sztul & J Louhelainen. (1999) Molecular and cellular alterations in tobacco smoke-associated larynx cancer. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 445:2, pages 259-274.
Crossref
Werner K Lutz. (1999) Carcinogens in the diet vs. overnutrition. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 443:1-2, pages 251-258.
Crossref
H. Raunio, J. Hakkola, J. Hukkanen, A. Lassila, K. Päivärinta, O. Pelkonen, S. Anttila, R. Piipari, A. Boobis & R.J. Edwards. (1999) Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue. Experimental and Toxicologic Pathology 51:4-5, pages 412-417.
Crossref
Sai-Mei Hou, Ke Yang, Fredrik Nyberg, Kari Hemminki, Göran Pershagen & Bo Lambert. (1999) Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls. Carcinogenesis 20:3, pages 437-444.
Crossref
G Gabbani, S Pavanello, B Nardini, O Tognato, A Bordin, C.Veller Fornasa, G Bezze & E Clonfero. (1999) Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 440:1, pages 27-33.
Crossref
A Hirvonen. (1999) Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.. Environmental Health Perspectives 107:suppl 1, pages 37-47.
Crossref
Wylie Burke. 1999. Cancer Genetics for the Clinician. Cancer Genetics for the Clinician 55 64 .
Sirkku T. Saarikoski, Anu Voho, Maria Reinikainen, Sisko Anttila, Antti Karjalainen, Christian Malaveille, Harri Vainio, Kirsti Husgafvel-Pursiainen & Ari Hirvonen. (1998) Combined effect of polymorphicGST genes on individual susceptibility to lung cancer. International Journal of Cancer 77:4, pages 516-521.
Crossref
John A. Timbrell. (1998) Biomarkers in toxicology. Toxicology 129:1, pages 1-12.
Crossref
Sirkku T. Saarikoski, Kirsti Husgafvel-Pursiainen, Ari Hirvonen, Harri Vainio, Frank J. Gonzalez & Sisko Anttila. (1998) Localization of CYP1A1 mRNA in human lung byin situ hybridization: Comparison with immunohistochemical findings. International Journal of Cancer 77:1, pages 33-39.
Crossref
F. Peter Guengerich & Tsutomu Shimada. (1998) Activation of procarcinogens by human cytochrome P450 enzymes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 400:1-2, pages 201-213.
Crossref
J A Grassman, S A Masten, N J Walker & G W Lucier. (1998) Animal models of human response to dioxins.. Environmental Health Perspectives 106:suppl 2, pages 761-775.
Crossref
Richard C Strange, John T Lear & Anthony A Fryer. (1998) Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chemico-Biological Interactions 111-112, pages 351-364.
Crossref
M.H Depledge. (1998) The ecotoxicological significance of genotoxicity in marine invertebrates. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 399:1, pages 109-122.
Crossref
Tiziana Martone, Luisa Airoldi, Cinzia Magagnotti, Renato Coda, Donato Randone, Christian Malaveille, Giancarlo Avanzi, Franco Merletti, Agnes Hautefeuille & Paolo Vineis. (1998) 4-aminobiphenyl-DNA adducts and p53 mutations in bladder cancer. International Journal of Cancer 75:4, pages 512-516.
Crossref
Seymour GarteSeymour Garte. 1998. Genetic Susceptibility to Cancer. Genetic Susceptibility to Cancer 103 109 .
Seymour GarteSeymour Garte. 1998. Genetic Susceptibility to Cancer. Genetic Susceptibility to Cancer 89 101 .
Seymour GarteSeymour Garte. 1998. Genetic Susceptibility to Cancer. Genetic Susceptibility to Cancer 75 88 .
Roman A. McLellan, Mikael Oscarson, Anna-Karin Alexandrie, Janeric Seidegård, David A. Price Evans, Agneta Rannug & Magnus Ingelman-Sundberg. (1997) Characterization of a Human Glutathione S -Transferase μ Cluster Containing a Duplicated GSTM1 Gene that Causes Ultrarapid Enzyme Activity . Molecular Pharmacology 52:6, pages 958-965.
Crossref
Rashmi Sinha & Neil Caporaso. (1997) Heterocyclic amines, cytochrome P4501A2, and N-acetyltransferase: Issues involved in incorporating putative genetic susceptibility markers into epidemiological studies. Annals of Epidemiology 7:5, pages 350-356.
Crossref
Robert Nilsson. 1997. What Risk?. What Risk? 96 150 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.